This Crypto Is Set to Explode in December

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Rebecca M. Henderson net worth and biography

Rebecca Henderson Biography and Net Worth

Director of IDEXX Laboratories

Dr. Rebecca M. Henderson Ph.D. serves as Independent Director of the Company. Dr. Henderson has been the John and Natty McArthur University Professor at Harvard University since 2011. Before joining Harvard’s faculty, from 1998 to 2009 Dr. Henderson served as the Eastman Kodak Professor of Management, Sloan School of the Massachusetts Institute of Technology. Dr. Henderson is also a research fellow at the National Bureau of Economic Research and a fellow of both the British Academy and of the American Academy of Arts and Sciences. Dr. Henderson holds an undergraduate degree from the Massachusetts Institute of Technology and a PhD in business economics from Harvard University. As a Harvard Business School professor of general management and strategy and an author of both books and articles regarding sustainability, strategy and innovation, Dr. Henderson brings substantial expertise in corporate strategy, sustainability, compensation practices, corporate responsibility and governance issues, with a particular focus on high-technology businesses. This expertise, combined with her deep knowledge of and insight into our businesses, operations and organization from her more than fifteen years of service on the Board, uniquely positions Dr. Henderson to offer valuable insights into the organizational and strategic issues faced by IDEXX.

What is Rebecca M. Henderson's net worth?: The estimated net worth of Rebecca M. Henderson is at least $7.31 million as of February 23rd, 2021. Dr. Henderson owns 17,742 shares of IDEXX Laboratories stock worth more than $7,314,317 as of December 21st. This net worth estimate does not reflect any other assets that Dr. Henderson may own. Learn More about Rebecca M. Henderson's net worth.
How do I contact Rebecca M. Henderson?: The corporate mailing address for Dr. Henderson and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Rebecca M. Henderson's contact information.
Has Rebecca M. Henderson been buying or selling shares of IDEXX Laboratories?: Rebecca M. Henderson has not been actively trading shares of IDEXX Laboratories in the last ninety days. Most recently, Rebecca M. Henderson sold 3,046 shares of the business's stock in a transaction on Tuesday, February 23rd. The shares were sold at an average price of $513.41, for a transaction totalling $1,563,846.86. Following the completion of the sale, the director now directly owns 17,742 shares of the company's stock, valued at $9,108,920.22. Learn More on Rebecca M. Henderson's trading history.
Who are IDEXX Laboratories' active insiders?: IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.
Are insiders buying or selling shares of IDEXX Laboratories?: During the last year, insiders at the sold shares 5 times. They sold a total of 44,068 shares worth more than $25,124,750.88. The most recent insider tranaction occured on November, 27th when Director Sophie V Vandebroek sold 344 shares worth more than $144,631.36. Insiders at IDEXX Laboratories own 2.1% of the company. Learn More about insider trades at IDEXX Laboratories.
Information on this page was last updated on 11/27/2024.

Rebecca M. Henderson Insider Trading History at IDEXX Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2021	Sell	3,046	$513.41	$1,563,846.86	17,742
11/10/2020	Sell	5,902	$435.91	$2,572,740.82	20,598
5/13/2020	Sell	13,396	$286.66	$3,840,097.36	20,670
8/14/2019	Sell	4,000	$271.17	$1,084,680.00	14,696
5/13/2019	Sell	8,790	$241.57	$2,123,400.30	27,486
11/27/2018	Sell	3,504	$194.92	$682,999.68	22,200
8/23/2017	Sell	5,156	$153.29	$790,363.24	17,274
8/22/2017	Sell	2,578	$152.86	$394,073.08	17,274
5/4/2017	Sell	1,700	$159.95	$271,915.00	21,552
8/25/2016	Sell	9,924	$110.43	$1,095,907.32	16,678
11/12/2015	Sell	2,300	$68.39	$157,297.00	21,450
2/5/2015	Sell	2,934	$156.27	$458,496.18

Rebecca M. Henderson Buying and Selling Activity at IDEXX Laboratories

IDEXX Laboratories Company Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Today's Range

Now: $412.26

$404.36

$418.26

50 Day Range

MA: $433.90

$406.92

$478.00

2 Week Range

Now: $412.26

$398.50

$583.39

Volume

1,122,179 shs

Average Volume

516,185 shs

Market Capitalization

$33.76 billion

P/E Ratio

39.76

Dividend Yield

N/A

Beta

1.37

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad